COVID-19 has expanded across the world since its discovery in Wuhan (China) and has
had a significant impact on people's lives and health. Long COVID is a term coined by the …

COVID-19 vaccines were developed and approved rapidly in response to the urgency
created by the pandemic. No specific regulations existed at the time they were marketed …

The occurrence of a novel coronavirus known as severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has …

Almost 20% of COVID-19 patients have a history of atrial fibrillation (AF), but also a new-
onset AF represents a frequent complication in COVID-19. Clinical evidence demonstrates …

Liver damage is a common sequela of COVID-19 (coronavirus disease 2019), worsening
the clinical outcomes. However, the underlying mechanism of COVID-induced liver injury …

In 2020, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) challenged the
world with a global outbreak that led to millions of deaths worldwide. Coronavirus disease …

The SARS-CoV-2 virus has caused a pandemic, infecting nearly 80 million people
worldwide, with mortality exceeding six million. The average survival span is just 14 days …

The rapid growth of vascular smooth muscle cells (VSMCs) represents crucial pathological
changes during the development of hypertensive vascular remodeling. Although quercetin …

Aprotinin is a broad-spectrum inhibitor of human proteases that has been approved for the
treatment of bleeding in single coronary artery bypass surgery because of its potent …

A few days after being infected with SARS-CoV-2, a fraction of people remain asymptomatic
but suffer from a decrease in arterial oxygen saturation in the absence of apparent dyspnea …